Side Effects Related to Cancer Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Side Effects Related to Cancer Treatment

Published:2005-11-20 Issue:33 Volume:23 Page:8531-8533
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ho Cheryl¹,Davis Jennifer²,Anderson Frank³,Bebb Gwyn⁴,Murray Nevin¹

Affiliation:

1. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

2. Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada

3. Department of Gastroenterology, Vancouver General Hospital, Vancouver, British Columbia, Canada

4. Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.00.6650

Reference5 articles.

1. Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

2. Forsythe B and Faulkner K: Clinical experience with gefitinib (′Iressa’, ZD1839): an overview of safety and tolerability. Lung Cancer 41: 2003 (abstr O-240)

3. Severe acute interstitial pneumonia and gefitinib

4. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

5. Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting;Oncology Letters;2023-10-18

2. Liver Pathology Related to Onco-Therapeutic Agents;Surgical Pathology Clinics;2023-09

3. FOXO3 mutation predicting gefitinib-induced hepatotoxicity in NSCLC patients through regulation of autophagy;Acta Pharmaceutica Sinica B;2022-09

4. A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids;International Journal of Molecular Sciences;2022-02-17

5. Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians;Critical Reviews in Oncology/Hematology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3